93. Primary biliary cholangitis
230 clinical trials,   215 drugs   (DrugBank: 51 drugs),   34 drug target genes,   107 drug target pathways
Searched query = "Primary biliary cholangitis", "Primary biliary cirrhosis", "PBC"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT00490620 (ClinicalTrials.gov) | January 2004 | 21/6/2007 | Study of Combivir for Patients With Primary Biliary Cirrhosis | Randomized Controlled Pilot Study of Combivir for Patients With Primary Biliary Cirrhosis | Primary Biliary Cirrhosis | Drug: Combination antiviral therapy;Drug: Placebo | University of Alberta | GlaxoSmithKline;Axcan Pharma | Completed | 18 Years | 75 Years | Both | 59 | Phase 2;Phase 3 | United States;Canada;United Kingdom |